Could an ADHD pill help kids with sickle cell disease focus in school?
NCT ID NCT07226219
Summary
This study is testing if a daily ADHD medication called methylphenidate is practical, safe, and acceptable for children with sickle cell disease who struggle with attention, memory, and thinking. About 30 children, aged 8 to 18, will take the medication once a day for four weeks. Researchers will check if families can stick to the routine, monitor for side effects, and see if the children's focus and schoolwork improve.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.